Drug Evaluation During the COVID-19 Pandemic

Rome BN, Avorn J - New England Journal of Medicine

  • Regulation and Clinical Evidence

Summary:

The authors discuss the importance of maintaining rigorous Medicaid coverage during the COVID-19 pandemic and argue against proposals to cap federal Medicaid contributions, emphasizing that Medicaid expansion is a rapid, proven way to bring needed resources into the health care system during a crisis.

VIEW SOURCE

Recent Work from PORTAL

Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway

Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy

  • Price, Value, and Access
  • Regulation and Clinical Evidence
Talk bubble graphics representing commentary and opinion.

Politics and the Patient Encounter, in Dire Times

Avorn J - MedPage Today

  • Regulation and Clinical Evidence